Cardinal Health Gets Warning Letter Over Defective Monoject Syringes
FDA never approved recent changes in manufacturers and new dimensions for the syringe sizes, which led to a massive Monoject syringe recall earlier this year
FDA never approved recent changes in manufacturers and new dimensions for the syringe sizes, which led to a massive Monoject syringe recall earlier this year
The FDA has declared a February product correction as a Class I Monoject syringe recall, following numerous reports of problems with the new syringes' dimensions.
The FDA first warned of problems with Cardinal Health Monoject syringes failing to fit drug pumps in November 2023.
Warning comes after Cardinal Health recalled more than 32 million syringes in September, because they may not fit correctly into certain pain management drug pumps.